Early Phase 1 Skin Clinical Trials
5 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–5 of 5 trials
Recruiting
Early Phase 1
Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders
Skin Diseases
Northwestern University30 enrolled1 locationNCT05649098
Recruiting
Early Phase 1
Pilot Trial of Supplemental Vitamin A and Nicotinamide
Skin CancerKidney Transplant Recipients
Rhode Island Hospital30 enrolled1 locationNCT05702398
Recruiting
Early Phase 1
Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma
Skin Squamous Cell CarcinomaSkin Basal Cell CarcinomaSkin Nodular Basal Cell Carcinoma
Kirsten Johnson40 enrolled1 locationNCT07144384
Recruiting
Early Phase 1
A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision
Cutaneous Squamous Cell CancerSkin CancerCutaneous Squamous Cell Carcinoma (CSCC)
Dana-Farber Cancer Institute25 enrolled2 locationsNCT06664151
Recruiting
Early Phase 1
CivaDerm(TM) Surface Therapy Pilot Study
Basal Cell CarcinomaSquamous Cell Carcinoma of the Skin
CivaTech Oncology10 enrolled1 locationNCT04480645